Hans Peter Hasler, EVP, Global Neurology, Int'l at BIOGEN IDEC INC. (BIIB), sold 7,663 shares at $64.85 ($494K) on 2008-04-08, disclosed to the SEC on 2008-04-10.
Scheduled sale ($494k) by EVP, Global Neurology, Int'l under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.75 | 100 | $6K | 1.3% |
| 2 | $63.83 | 200 | $13K | 2.6% |
| 3 | $63.89 | 200 | $13K | 2.6% |
| 4 | $63.93 | 100 | $6K | 1.3% |
| 5 | $64.13 | 200 | $13K | 2.6% |
| 6 | $64.14 | 100 |
| $6K |
| 1.3% |
| 7 | $64.19 | 200 | $13K | 2.6% |
| 8 | $64.31 | 300 | $19K | 3.9% |
| 9 | $64.32 | 200 | $13K | 2.6% |
| 10 | $64.41 | 200 | $13K | 2.6% |
| 11 | $64.42 | 900 | $58K | 11.7% |
| 12 | $64.43 | 200 | $13K | 2.6% |
| 13 | $64.45 | 300 | $19K | 3.9% |
| 14 | $64.47 | 63 | $4K | 0.8% |
| 15 | $64.51 | 300 | $19K | 3.9% |
| 16 | $64.53 | 600 | $39K | 7.8% |
| 17 | $64.55 | 300 | $19K | 3.9% |
| 18 | $64.63 | 200 | $13K | 2.6% |
| 19 | $64.70 | 300 | $19K | 3.9% |
| 20 | $64.72 | 200 | $13K | 2.6% |
| 21 | $64.74 | 300 | $19K | 3.9% |
| 22 | $64.79 | 100 | $6K | 1.3% |
| 23 | $64.80 | 200 | $13K | 2.6% |
| 24 | $64.81 | 200 | $13K | 2.6% |
| 25 | $64.82 | 400 | $26K | 5.2% |
| 26 | $64.84 | 200 | $13K | 2.6% |
| 27 | $64.85 | 100 | $6K | 1.3% |
| 28 | $64.86 | 400 | $26K | 5.2% |
| 29 | $64.88 | 200 | $13K | 2.6% |
| 30 | $64.89 | 400 | $26K | 5.2% |
| Total | $64.53 avg | 7,663 | $494K | 100% |
| Filing → |
| BIIB | SELL | 2009-02-13 | $261K | — | Filing → |
| BIIB | SELL | 2008-11-07 | $37K | — | Filing → |
| BIIB | SELL | 2008-07-24 | $898K | — | Filing → |